- Home
- ALRN vs MPU Comparison
ALRN vs MPU Comparison
Compare ALRN & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRN
- MPU
- Stock Information
- Founded
- ALRN 2001
- MPU 1989
- Country
- ALRN United States
- MPU Singapore
- Employees
- ALRN N/A
- MPU N/A
- Industry
- ALRN Biotechnology: Pharmaceutical Preparations
- MPU Transportation Services
- Sector
- ALRN Health Care
- MPU Consumer Discretionary
- Exchange
- ALRN Nasdaq
- MPU Nasdaq
- Market Cap
- ALRN 76.9M
- MPU 66.0M
- IPO Year
- ALRN 2017
- MPU 1998
- Fundamental
- Price
- ALRN $1.92
- MPU $1.71
- Analyst Decision
- ALRN Strong Buy
- MPU
- Analyst Count
- ALRN 1
- MPU 0
- Target Price
- ALRN $19.00
- MPU N/A
- AVG Volume (30 Days)
- ALRN 92.8K
- MPU 115.9K
- Earning Date
- ALRN 11-14-2024
- MPU 11-12-2024
- Dividend Yield
- ALRN N/A
- MPU N/A
- EPS Growth
- ALRN N/A
- MPU N/A
- EPS
- ALRN N/A
- MPU N/A
- Revenue
- ALRN N/A
- MPU $26,001,000.00
- Revenue This Year
- ALRN N/A
- MPU N/A
- Revenue Next Year
- ALRN N/A
- MPU N/A
- P/E Ratio
- ALRN N/A
- MPU N/A
- Revenue Growth
- ALRN N/A
- MPU 1444400.00
- 52 Week Low
- ALRN $1.61
- MPU $0.77
- 52 Week High
- ALRN $7.42
- MPU $4.48
- Technical
- Relative Strength Index (RSI)
- ALRN 29.69
- MPU 50.01
- Support Level
- ALRN $1.85
- MPU $1.66
- Resistance Level
- ALRN $2.38
- MPU $1.79
- Average True Range (ATR)
- ALRN 0.30
- MPU 0.15
- MACD
- ALRN -0.01
- MPU -0.02
- Stochastic Oscillator
- ALRN 6.31
- MPU 20.59
About ALRN Aileron Therapeutics Inc.
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.
About MPU Mega Matrix Corp.
Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment.